Monday 26 February 2018

NHS could have spent up to £500million unnecessarily by telling doctors to prescribe more expensive drug

NHS could have spent up to £500million unnecessarily by telling doctors to prescribe more expensive drug The NHS could recover up to £500 million from one of the world’s largest pharmaceutical companies following a lengthy legal battle over the patent for one of its drugs.

The health service took the “unprecedented” step of issuing guidance to all GPs and pharmacists stating that when prescribing the drug pregabalin for neuropathic pain they should stipulate that it must be the brand Lyrica, produced by Pfizer. The Daily Telegraph

No comments:

Post a Comment